ECG left ventricular hypertrophy in aortic stenosis: Relationship with cardiac structure, invasive hemodynamics, and

Patrizia Sager1,2, Andreas Rusch1,3, Lukas Weber1

  • 1Department of Cardiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.

Clinical Cardiology
|September 23, 2023
PubMed

Insights

The Peguero-Lo Presti score effectively predicts left ventricular hypertrophy and cardiac damage in severe aortic stenosis patients. This ECG-based score also indicates long-term mortality risk following aortic valve replacement.

Area of Science:

  • Cardiology
  • Medical Diagnostics
  • Cardiac Surgery

Background:

  • Left ventricular hypertrophy (LVH) is a response to pressure overload in aortic stenosis (AS).
  • AS-related cardiac damage can follow LVH, impacting patient prognosis.
  • Electrocardiogram (ECG) LVH may predict cardiac damage and outcomes after aortic valve replacement (AVR).

Purpose of the Study:

  • To evaluate if ECG-derived LVH predicts echocardiographic LVH in AS patients.
  • To determine if ECG-derived LVH predicts other markers of cardiac damage.
  • To assess the prognostic value of ECG LVH for mortality after AVR.

Main Methods:

  • 279 severe AS patients undergoing ECG, echocardiography, and cardiac catheterization before AVR were studied.
  • Sokolow-Lyon index, Cornell product, Romhilt-Estes score, and Peguero-Lo Presti score were assessed.
  • Correlation with echocardiographic LVH, invasive cardiac damage markers, and all-cause mortality post-AVR was analyzed.

Main Results:

  • The Peguero-Lo Presti score showed the highest AUC for predicting echocardiographic LVH.
  • This score also best predicted invasive measures of cardiac damage, including elevated filling pressures and pulmonary resistance.
  • The Peguero-Lo Presti score was significantly associated with all-cause mortality after AVR.

Conclusions:

  • The Peguero-Lo Presti score is a valuable tool for assessing cardiac abnormalities in severe AS.
  • It correlates with LVH, invasive cardiac damage markers, and predicts long-term mortality post-AVR.
  • ECG assessment using the Peguero-Lo Presti score can aid in risk stratification for AS patients.
Abstract

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
23
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
15
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
10
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
15